Tag: Actavis Laboratories UT

May 15, 2017 Off

US District Court upholds Horizon Pharma’s patent

By Dino Mustafić

The United States District Court for the District of New Jersey upheld the validity of Horizon Pharma’s patent covering Pennsaid (diclofenac sodium topical solution) 2% w/w, which Actavis Laboratories UT, Inc.(Actavis) has admitted that its proposed generic diclofenac sodium topical solution product would infringe.